{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:24:13Z","timestamp":1792783453453,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":90,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Natural Science Foundation of Hunan Province","award":["2023JJ50305"],"award-info":[{"award-number":["2023JJ50305"]}]},{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","award":["320.6750.2023-18-88"],"award-info":[{"award-number":["320.6750.2023-18-88"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shenzhen Nanshan District Health Bureau","award":["NSZD2024042"],"award-info":[{"award-number":["NSZD2024042"]}]},{"name":"Tongji Hospital Clinical Trial Program","award":["2024TJCR015"],"award-info":[{"award-number":["2024TJCR015"]}],"id":[{"id":"https:\/\/ror.org\/04xy45965","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Hubei Provincial Department of Science and Technology Key Project","award":["2023BCB088"],"award-info":[{"award-number":["2023BCB088"]}],"id":[{"id":"https:\/\/ror.org\/05a7g7f24","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05553-5","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T13:37:39Z","timestamp":1783690659000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cancer-associated adipocytes promote breast cancer progression by upregulating miR-106b-3p to target SLK"],"prefix":"10.1007","volume":"17","author":[{"given":"Xiaomei","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"issue":"January","key":"5553_CR1","doi-asserted-by":"publisher","first-page":"102339","DOI":"10.1016\/j.ctrv.2022.102339","volume":"104","author":"D Trapani","year":"2022","unstructured":"Trapani D, Ginsburg O, Fadelu T, Lin NU, Hassett M, Ilbawi AM, Anderson BO, Curigliano G. Global challenges and policy solutions in breast cancer control. Cancer Treat Rev. 2022;104(January):102339.","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"5553_CR2","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13045-019-0778-6","volume":"12","author":"Q Wu","year":"2019","unstructured":"Wu Q, Li B, Li Z, Li J, Sun S, Sun S. Cancer-associated adipocytes: key players in breast cancer progression. J Hematol Oncol. 2019;12(1):95.","journal-title":"J Hematol Oncol"},{"issue":"7","key":"5553_CR3","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1158\/0008-5472.CAN-10-3323","volume":"71","author":"B Dirat","year":"2011","unstructured":"Dirat B, Bochet L, Dabek M, Daviaud D, Dauvillier S, Majed B, Wang YY, Meulle A, Salles B, Le Gonidec S, Garrido I, Escourrou G, Valet P, Muller C. Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion. Cancer Res. 2011;71(7):2455\u201365.","journal-title":"Cancer Res"},{"issue":"1","key":"5553_CR4","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s13046-022-02408-z","volume":"41","author":"X Zhou","year":"2022","unstructured":"Zhou X, Zhang J, Lv W, Zhao C, Xia Y, Wu Y, Zhang Q. The pleiotropic roles of adipocyte secretome in remodeling breast cancer. J Exp Clin Cancer Res. 2022;41(1):203.","journal-title":"J Exp Clin Cancer Res"},{"issue":"6","key":"5553_CR5","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.tig.2022.02.006","volume":"38","author":"C Diener","year":"2022","unstructured":"Diener C, Keller A, Meese E. Emerging concepts of miRNA therapeutics: from cells to clinic. Trends Genet. 2022;38(6):613\u201326.","journal-title":"Trends Genet"},{"issue":"4","key":"5553_CR6","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1042\/CS20191087","volume":"134","author":"H Liu","year":"2020","unstructured":"Liu H, Liu Y, Sun P, Leng K, Xu Y, Mei L, Han P, Zhang B, Yao K, Li C, Bai J, Cui B. Colorectal cancer-derived exosomal miR-106b-3p promotes metastasis by down-regulating DLC-1 expression. Clin Sci (Lond). 2020;134(4):419\u201334.","journal-title":"Clin Sci (Lond)"},{"issue":"8","key":"5553_CR7","doi-asserted-by":"publisher","first-page":"e004832","DOI":"10.1136\/jitc-2022-004832","volume":"10","author":"H-Y Cheng","year":"2022","unstructured":"Cheng H-Y, Hsieh C-H, Lin P-H, Chen Y-T, Hsu DS-S, Tai S-K, Chu P-Y, Yang M-H. Snail-regulated exosomal microRNA-21 suppresses NLRP3 inflammasome activity to enhance cisplatin resistance. J Immunother cancer. 2022;10(8):e004832.","journal-title":"J Immunother cancer"},{"issue":"1","key":"5553_CR8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13046-022-02553-5","volume":"42","author":"F Orso","year":"2023","unstructured":"Orso F, Virga F, Dettori D, Dalmasso A, Paradzik M, Savino A, et al. Stroma-derived miR-214 coordinates tumor dissemination. J Exp Clin Cancer Res. 2023;42(1):20.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"5553_CR9","doi-asserted-by":"publisher","first-page":"7734","DOI":"10.1038\/s41467-022-35305-2","volume":"13","author":"D Zhao","year":"2022","unstructured":"Zhao D, Wu K, Sharma S, Xing F, Wu S-Y, Tyagi A, et al. Exosomal miR-1304-3p promotes breast cancer progression in African Americans by activating cancer-associated adipocytes. Nat Commun. 2022;13(1):7734.","journal-title":"Nat Commun"},{"issue":"1","key":"5553_CR10","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s13045-020-01005-x","volume":"13","author":"M Hong","year":"2020","unstructured":"Hong M, Tao S, Zhang L, Diao L-T, Huang X, Huang S, Xie S-J, Xiao Z-D, Zhang H. RNA sequencing: new technologies and applications in cancer research. J Hematol Oncol. 2020;13(1):166.","journal-title":"J Hematol Oncol"},{"issue":"7","key":"5553_CR11","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/s41575-021-00471-z","volume":"18","author":"J Han","year":"2021","unstructured":"Han J, DePinho RA, Maitra A. Single-cell RNA sequencing in pancreatic cancer. Nat Rev Gastroenterol Hepatol. 2021;18(7):451\u201352.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"5553_CR12","doi-asserted-by":"publisher","first-page":"e08886","DOI":"10.1016\/j.heliyon.2022.e08886","volume":"8","author":"K De Silva","year":"2022","unstructured":"De Silva K, Demmer RT, J\u00f6nsson D, Mousa A, Forbes A, Enticott J. A data-driven biocomputing pipeline with meta-analysis on high throughput transcriptomics to identify genome-wide miRNA markers associated with type 2 diabetes. Heliyon. 2022;8(2):e08886.","journal-title":"Heliyon"},{"issue":"20","key":"5553_CR13","doi-asserted-by":"publisher","first-page":"15350","DOI":"10.18632\/oncotarget.24601","volume":"9","author":"F Moshiri","year":"2018","unstructured":"Moshiri F, Salvi A, Gramantieri L, Sangiovanni A, Guerriero P, De Petro G, et al. Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma. Oncotarget. 2018;9(20):15350\u201364.","journal-title":"Oncotarget"},{"issue":"4","key":"5553_CR14","first-page":"1817","volume":"43","author":"G Qiao","year":"2019","unstructured":"Qiao G, Dai C, He Y, Shi J, Xu C. Effects of miR\u2013106b\u20133p on cell proliferation and epithelial\u2013mesenchymal transition, and targeting of ZNRF3 in esophageal squamous cell carcinoma. Int J Mol Med. 2019;43(4):1817\u201329.","journal-title":"Int J Mol Med"},{"issue":"4","key":"5553_CR15","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1042\/CS20191087","volume":"134","author":"H Liu","year":"2020","unstructured":"Liu H, Liu Y, Sun P, Leng K, Xu Y, Mei L, et al. Colorectal cancer-derived exosomal miR-106b-3p promotes metastasis by down-regulating DLC-1 expression. Clin Sci (Lond). 2020;134(4):419\u201334.","journal-title":"Clin Sci (Lond)"},{"issue":"16","key":"5553_CR16","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1007\/s40265-020-01394-w","volume":"80","author":"SE Nunnery","year":"2020","unstructured":"Nunnery SE, Mayer IA. Targeting the PI3K\/AKT\/mTOR pathway in hormone-positive breast cancer. Drugs. 2020;80(16):1685\u201397.","journal-title":"Drugs"},{"issue":"5","key":"5553_CR17","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1158\/2159-8290.CD-20-1211","volume":"11","author":"P Dey","year":"2021","unstructured":"Dey P, Kimmelman AC, DePinho RA. Metabolic codependencies in the tumor microenvironment. Cancer Discov. 2021;11(5):1067\u201381.","journal-title":"Cancer Discov"},{"issue":"2","key":"5553_CR18","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s10549-015-3318-2","volume":"150","author":"K Fujisaki","year":"2015","unstructured":"Fujisaki K, Fujimoto H, Sangai T, Nagashima T, Sakakibara M, Shiina N, et al. Cancer-mediated adipose reversion promotes cancer cell migration via IL-6 and MCP-1. Breast Cancer Res Treat. 2015;150(2):255\u201363.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"5553_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-27210-w","volume":"8","author":"A Nickel","year":"2018","unstructured":"Nickel A, Bl\u00fccher C, Kadri OA, Schwagarus N, M\u00fcller S, Schaab M, et al. Adipocytes induce distinct gene expression profiles in mammary tumor cells and enhance inflammatory signaling in invasive breast cancer cells. Sci Rep. 2018;8(1):9482.","journal-title":"Sci Rep"},{"issue":"5","key":"5553_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pharmaceutics12050402","volume":"12","author":"R Munteanu","year":"2020","unstructured":"Munteanu R, Onaciu A, Moldovan C, Zimta AA, Gulei D, Paradiso AV, Lazar V, Berindan-Neagoe I. Adipocyte-based cell therapy in oncology: the role of cancer-associated adipocytes and their reinterpretation as delivery platforms. Pharmaceutics. 2020;12(5):1\u201332.","journal-title":"Pharmaceutics"},{"issue":"4","key":"5553_CR21","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.7150\/ijbs.65227","volume":"18","author":"C Zhou","year":"2022","unstructured":"Zhou C, He X, Tong C, Li H, Xie C, Wu Y, Wang L, Yan X, Luo D, Tang Y, Cheng Z, Xiong X. Cancer-associated adipocytes promote the invasion and metastasis in breast cancer through LIF\/CXCLs positive feedback loop. Int J Biol Sci. 2022;18(4):1363\u201380.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"5553_CR22","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1186\/s12885-023-10826-1","volume":"23","author":"C Zhao","year":"2023","unstructured":"Zhao C, Zeng N, Zhou X, Tan Y, Wang Y, Zhang J, Wu Y, Zhang Q. CAA-derived IL-6 induced M2 macrophage polarization by activating STAT3. BMC Cancer. 2023;23(1):392.","journal-title":"BMC Cancer"},{"key":"5553_CR23","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.semcancer.2020.05.017","volume":"72","author":"D Sengupta","year":"2021","unstructured":"Sengupta D, Deb M, Kar S, Pradhan N, Parbin S, Kirtana R, Singh SP, Suma SG, Niharika Roy A, Manna S, Saha P, Chakraborty P, Dash S, Kausar C, Patra SK. Dissecting miRNA facilitated physiology and function in human breast cancer for therapeutic intervention. Semin Cancer Biol. 2021;72:46\u201364.","journal-title":"Semin Cancer Biol"},{"key":"5553_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111528","volume":"138","author":"BM Hussen","year":"2021","unstructured":"Hussen BM, Hidayat HJ, Salihi A, Sabir DK, Taheri M, Ghafouri-Fard S. MicroRNA: a signature for cancer progression. Biomed Pharmacother. 2021;138:111528.","journal-title":"Biomed Pharmacother"},{"issue":"27","key":"5553_CR25","doi-asserted-by":"publisher","first-page":"41575","DOI":"10.18632\/oncotarget.9491","volume":"7","author":"Z Cao","year":"2016","unstructured":"Cao Z, Liu C, Xu J, You L, Wang C, Lou W, Sun B, Miao Y, Liu X, Wang X, Zhang T, Zhao Y. Plasma microRNA panels to diagnose pancreatic cancer: results from a multicenter study. Oncotarget. 2016;7(27):41575\u201383.","journal-title":"Oncotarget"},{"issue":"6","key":"5553_CR26","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3892\/mmr.2021.12110","volume":"23","author":"Y Zhu","year":"2021","unstructured":"Zhu Y, Zhang Y, Li X, Su Y, Wang N, Chen M, Yang Z. Downregulation of miR\u2013106b\u20133p increases sensitivity to cisplatin in esophageal cancer cells by targeting TGM3. Mol Med Rep. 2021;23(6):471.","journal-title":"Mol Med Rep"},{"issue":"58","key":"5553_CR27","doi-asserted-by":"publisher","first-page":"98745","DOI":"10.18632\/oncotarget.21928","volume":"8","author":"J Conway","year":"2017","unstructured":"Conway J, Al-Zahrani KN, Pryce BR, Abou-Hamad J, Sabourin LA. Transforming growth factor \u03b2-induced epithelial to mesenchymal transition requires the Ste20-like kinase SLK independently of its catalytic activity. Oncotarget. 2017;8(58):98745\u201356.","journal-title":"Oncotarget"},{"key":"5553_CR28","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.258269","author":"B Garland","year":"2021","unstructured":"Garland B, Delisle S, Al-Zahrani KN, Pryce BR, Sabourin LA. The Ste20-like kinase - a jack of all trades? J Cell Sci. 2021. https:\/\/doi.org\/10.1242\/jcs.258269.","journal-title":"J Cell Sci"},{"issue":"20","key":"5553_CR29","doi-asserted-by":"publisher","first-page":"3930","DOI":"10.1158\/0008-5472.CAN-25-0523","volume":"85","author":"Z Chen","year":"2025","unstructured":"Chen Z, Liao J, Zhu C, Chang R, Liang H, Ding Z, Huang Z, Chen X, Liang J, Zhang B. Exon skipping of Ste20-like kinase enhances glycolysis and tumor progression by activating enolase 1-mediated phosphoenolpyruvate production. Cancer Res. 2025;85(20):3930\u201348.","journal-title":"Cancer Res"},{"issue":"4","key":"5553_CR30","doi-asserted-by":"publisher","first-page":"F971","DOI":"10.1152\/ajprenal.00294.2009","volume":"297","author":"AV Cybulsky","year":"2009","unstructured":"Cybulsky AV, Takano T, Guillemette J, Papillon J, Volpini RA, Di Battista JA. The Ste20-like kinase SLK promotes p53 transactivation and apoptosis. Am J Physiol Renal Physiol. 2009;297(4):F971-80.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1","key":"5553_CR31","doi-asserted-by":"publisher","first-page":"F186","DOI":"10.1152\/ajprenal.00238.2017","volume":"315","author":"AV Cybulsky","year":"2018","unstructured":"Cybulsky AV, Papillon J, Guillemette J, Belkina N, Patino-Lopez G, Torban E. Ste20-like kinase, SLK, a novel mediator of podocyte integrity. Am J Physiol Ren Physiol. 2018;315(1):F186\u201398.","journal-title":"Am J Physiol Ren Physiol"},{"issue":"23","key":"5553_CR32","doi-asserted-by":"publisher","first-page":"4592","DOI":"10.1038\/s41388-020-1315-3","volume":"39","author":"KN Al-Zahrani","year":"2020","unstructured":"Al-Zahrani KN, Abou-Hamad J, Cook DP, Pryce BR, Hodgins JJ, Labr\u00e8che C, et al. Loss of the Ste20-like kinase induces a basal\/stem-like phenotype in HER2-positive breast cancers. Oncogene. 2020;39(23):4592\u2013602.","journal-title":"Oncogene"},{"issue":"31","key":"5553_CR33","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1038\/onc.2009.146","volume":"28","author":"K Roovers","year":"2009","unstructured":"Roovers K, Wagner S, Storbeck CJ, O\u2019Reilly P, Lo V, Northey JJ, Chmielecki J, Muller WJ, Siegel PM, Sabourin LA. The Ste20-like kinase SLK is required for ErbB2-driven breast cancer cell motility. Oncogene. 2009;28(31):2839\u201348.","journal-title":"Oncogene"},{"issue":"49","key":"5553_CR34","doi-asserted-by":"publisher","first-page":"31189","DOI":"10.1073\/pnas.2017152117","volume":"117","author":"J Yi","year":"2020","unstructured":"Yi J, Zhu J, Wu J, Thompson CB, Jiang X. Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis. Proc Natl Acad Sci U S A. 2020;117(49):31189\u201397.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"5553_CR35","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.1111\/cas.15900","volume":"114","author":"L Ma","year":"2023","unstructured":"Ma L, Huang W, Liang X, Bai G, Wang X, Jiang H, Xin Y, Hu L, Chen X, Liu C. Inhibition of squalene epoxidase linking with PI3K\/AKT signaling pathway suppresses endometrial cancer. Cancer Sci. 2023;114(9):3595\u2013607.","journal-title":"Cancer Sci"},{"issue":"7","key":"5553_CR36","doi-asserted-by":"publisher","first-page":"e18128","DOI":"10.1016\/j.heliyon.2023.e18128","volume":"9","author":"Z Xia","year":"2023","unstructured":"Xia Z, Zhao N, Liu M, Jiang D, Gao S, Ma P, Huang L. GPD1 inhibits the carcinogenesis of breast cancer through increasing PI3K\/AKT-mediated lipid metabolism signaling pathway. Heliyon. 2023;9(7):e18128.","journal-title":"Heliyon"},{"issue":"9","key":"5553_CR37","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.7150\/jca.37975","volume":"11","author":"J-Y Park","year":"2020","unstructured":"Park J-Y, Kang S-E, Ahn KS, Um J-Y, Yang WM, Yun M, Lee S-G. Inhibition of the PI3K-AKT-mTOR pathway suppresses the adipocyte-mediated proliferation and migration of breast cancer cells. J Cancer. 2020;11(9):2552\u201359.","journal-title":"J Cancer"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05553-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05553-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05553-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:55:34Z","timestamp":1791413734000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05553-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5553"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05553-5","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"assertion":[{"value":"6 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Institutional Ethics Committee of Yueyang Central Hospital (Yueyang, China) in November 4th, 2022. The ethical approval document was presented in additional file. The utilization and protocol of animals were approved by Animal Care and Use Committee, Huazhong University of Science and Technology. This study was carried out in compliance with the ARRIVE guidelines. The requirement to obtain informed consent was waived due to the retrospective nature of the study. The study was approved by the Institutional Ethics Committee of Yueyang Central Hospital (Yueyang, China). Due to the retrospective nature of the study using archived pathological specimens, the requirement for informed consent was waived by the ethics committee. All procedures involving human specimens were performed in accordance with the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent for publication was obtained from all participants.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1412"}}